{"organizations": [], "uuid": "32dbfb3a9ba3032810faca231981970b4b0e0103", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180306.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-editas-medicine-q4-loss-per-share/brief-editas-medicine-q4-loss-per-share-0-84-idUSASB0C91G", "country": "US", "domain_rank": 408, "title": "BRIEF-Editas Medicine Q4 Loss Per Share $0.84", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.026, "site_type": "news", "published": "2018-03-07T05:40:00.000+02:00", "replies_count": 0, "uuid": "32dbfb3a9ba3032810faca231981970b4b0e0103"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-editas-medicine-q4-loss-per-share/brief-editas-medicine-q4-loss-per-share-0-84-idUSASB0C91G", "ord_in_thread": 0, "title": "BRIEF-Editas Medicine Q4 Loss Per Share $0.84", "locations": [], "entities": {"persons": [{"name": "leber", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "editas medicine inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 6 (Reuters) - Editas Medicine Inc:\n* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND UPDATE\n* Q4 LOSS PER SHARE $0.84 * EDITAS MEDICINE - EDIT-101 FOR LEBER CONGENITAL AMAUROSIS TYPE 10 ON TRACK FOR MID-2018 INVESTIGATIONAL NEW DRUG FILING\n* YEAR-END CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $329 MILLION EXPECTED TO FUND BUSINESS FOR AT LEAST 24 MONTHS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T05:40:00.000+02:00", "crawled": "2018-03-07T19:45:13.028+02:00", "highlightTitle": ""}